Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-68,070
Closed -$2.06M 1702
2025
Q4
$2.06M Sell
68,070
-2,935
-4% -$72K 0.03% 537
2025
Q3
$1.41M Sell
71,005
-20,500
-22% -$429K 0.02% 737
2025
Q2
$2.28M Sell
91,505
-927
-1% -$20.9K 0.03% 532
2025
Q1
$2.17M Buy
92,432
+1,370
+2% +$39.7K 0.03% 521
2024
Q4
$2.55M Buy
91,062
+22,449
+33% +$602K 0.04% 483
2024
Q3
$1.4M Buy
68,613
+41,431
+152% +$928K 0.02% 672
2024
Q2
$803K Buy
27,182
+3,512
+15% +$101K 0.01% 833
2024
Q1
$722K Buy
23,670
+10,944
+86% +$309K 0.01% 862
2023
Q4
$298K Sell
12,726
-11,700
-48% -$283K 0.01% 1145
2023
Q3
$723K Buy
24,426
+12,860
+111% +$431K 0.01% 797
2023
Q2
$408K Buy
11,566
+160
+1% +$4.48K 0.01% 1048
2023
Q1
$275K Buy
11,406
+201
+2% +$4.66K 0.01% 1152
2022
Q4
$249K Buy
11,205
+450
+4% +$10.4K 0.01% 1155
2022
Q3
$256K Buy
+10,755
New +$290K 0.01% 1118
2022
Q2
Sell
-7,600
Closed -$312K 1430
2022
Q1
$312K Buy
+7,600
New +$396K 0.01% 1186

Other funds holding CFLT

Oppenheimer & Co's CFLT Position: Q1 2026 in Review

Oppenheimer & Co sold out of Confluent (CFLT) in Q1 2026, closing a stake of 68,070 shares — an estimated $2.06M sold.

Oppenheimer & Co first reported a position in CFLT in Q1 2022 and held it in 15 quarters. The position peaked at $2.55M in Q4 2024. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Oppenheimer & Co reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Oppenheimer & Co sold 68,070 Confluent shares in Q1 2026, an estimated $2.06M.
  • Oppenheimer & Co first reported a position in Confluent in Q1 2022 and held it in 15 quarters.
  • Oppenheimer & Co's Confluent position peaked at $2.55M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.